News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283 Results
Type
Article (28)
Press Release (255)
Section
Business (65)
Career Advice (1)
Deals (13)
Drug Development (8)
FDA (7)
Job Trends (7)
News (93)
Policy (4)
Tag
Academia (1)
Alliances (23)
Approvals (7)
Bankruptcy (1)
Career advice (1)
Clinical research (5)
COVID-19 (1)
Diagnostics (1)
Earnings (11)
Events (14)
FDA (7)
GLP-1 (1)
Healthcare (2)
Infectious disease (1)
IPO (3)
Job creations (5)
Job search strategy (1)
Layoffs (3)
Medical device (4)
Medtech (4)
Mergers & acquisitions (10)
NextGen Class of 2024 (1)
Northern California (2)
Pain (1)
People (15)
Phase I (2)
Phase II (3)
Phase III (3)
Real estate (9)
Regulatory (4)
Reports (2)
Startups (4)
United States (2)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (18)
2024 (18)
2023 (9)
2022 (51)
2021 (21)
2020 (20)
2019 (23)
2018 (11)
2017 (29)
2016 (42)
2015 (19)
2014 (13)
2013 (9)
2012 (4)
2011 (4)
2010 (4)
Location
Alabama (1)
Asia (9)
Australia (1)
California (2)
Europe (121)
Northern California (2)
283 Results for "evonik".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Evonik to Lay Off Additional Employees, Cutting up to 260 in Germany
Evonik’s latest layoffs are tied to discontinuing production of keto acids in Hanau, Germany, by the end of next year. Earlier this year, news broke the company is also cutting up to 2,000 employees globally by 2026.
October 14, 2024
·
1 min read
·
Angela Gabriel
Pharm Country
Modern Meadow and Evonik Join Forces to Revolutionize Clean Beauty with Animal-Free Collagen
Modern Meadow announced a groundbreaking partnership with Evonik, a leader in specialty ingredients for the beauty and personal care industry, to create sustainable, clean beauty products that are high-quality and animal-free.
May 2, 2023
·
3 min read
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, are working together to commercialize innovative 3D-printed scaffolds for bone regeneration.
March 6, 2023
·
4 min read
Business
Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan
Evonik has entered into a long-term supply agreement with Phathom Pharmaceuticals, a U.S. biopharmaceutical company focused on developing and commercializing new treatments for gastric acid-related diseases.
October 10, 2022
·
5 min read
Job Trends
Evonik to Build $220M Lipid Plant in U.S. for mRNA-Based Therapies
In partnership with the U.S. government, Evonik Industries is investing more than $200 million to build a lipid manufacturing facility in the United States.
June 2, 2022
·
3 min read
·
Alex Keown
Evonik sells TAeTTOOz® materials technology for printable rechargeable batteries to InnovationLab
Evonik is selling the TAeTTOOz® materials technology for printable rechargeable batteries to the InnovationLab GmbH. The InnovationLab specializes in the development of printed and organic electronics and offers individual overall solutions from the first concept draft to the industrial production.
May 24, 2022
·
3 min read
Pharm Country
Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
Evonik Industries AG, a leading global supplier of specialty chemicals, announced Monday their venture capital company’s strategic investment with Laxxon Medical Corporation.
March 8, 2022
·
3 min read
Business
No Opioids After Surgery: Evonik Invests in Allay Therapeutics and Supplies Key Technology for Pain Therapy Implants
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks.
December 13, 2022
·
5 min read
Business
Evonik Wins Governor’s Bioscience Award
Bio Nebraska announced that Evonik has been named the 2020 recipient of the Governor’s Bioscience Award, presented by Gov. Pete Ricketts.
October 28, 2020
·
3 min read
Business
DURECT Corporation to Sell its LACTEL® Absorbable Polymer Product Line to Evonik for $15 Million
DURECT Corporation (Nasdaq: DRRX) today announced that it has signed an agreement to sell its LACTEL Absorbable Polymer (LACTEL) product line to Evonik, a global leader in specialty chemicals. Under the terms of the agreement, Evonik will pay DURECT $15 million in exchange for certain assets and liabilities associated with
December 7, 2020
·
5 min read
1 of 29
Next